Details for New Drug Application (NDA): 021606
✉ Email this page to a colleague
The generic ingredient in ZEMPLAR is paricalcitol. There are ten drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the paricalcitol profile page.
Summary for 021606
Tradename: | ZEMPLAR |
Applicant: | Abbvie |
Ingredient: | paricalcitol |
Patents: | 0 |
Suppliers and Packaging for NDA: 021606
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZEMPLAR | paricalcitol | CAPSULE;ORAL | 021606 | NDA | AbbVie Inc. | 0074-9036 | 0074-9036-30 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0074-9036-30) |
ZEMPLAR | paricalcitol | CAPSULE;ORAL | 021606 | NDA | AbbVie Inc. | 0074-9037 | 0074-9037-30 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0074-9037-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 1MCG | ||||
Approval Date: | May 26, 2005 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 2MCG | ||||
Approval Date: | May 26, 2005 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 4MCG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | May 26, 2005 | TE: | RLD: | Yes |
Expired US Patents for NDA 021606
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | ZEMPLAR | paricalcitol | CAPSULE;ORAL | 021606-002 | May 26, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | ZEMPLAR | paricalcitol | CAPSULE;ORAL | 021606-003 | May 26, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | ZEMPLAR | paricalcitol | CAPSULE;ORAL | 021606-001 | May 26, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription